A National Securities Arbitration & Investment Fraud Law Firm

Facebook IconTwitter IconLinkedIn IconJustia IconFeed Icon

Articles Posted in Class Action

Published on:

Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Canopy Growth Corporation (CGC), a publicly-traded company involved in the production, distribution, and sale of cannabis in Canada, on behalf of shareholders of the company’s stock. The investigation concerns potential violations of federal securities laws.Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Canopy Growth Corporation (CGC), a publicly-traded company involved in the production, distribution, and sale of cannabis in Canada, on behalf of shareholders of the company’s stock.

The investigation concerns potential violations of federal securities laws. Continue reading

Published on:

Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN), a publicly-traded specialty pharmaceutical company, on behalf of shareholders of the company’s stock.  The investigation concerns whether Lipocine gave misleading information to the public and violated federal securities laws.Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN), a publicly-traded specialty pharmaceutical company, on behalf of shareholders of the company’s stock.

The investigation concerns whether Lipocine gave misleading information to the public and violated federal securities laws. Continue reading

Published on:

Silver Law Group is investigating Zynerba Pharmaceuticals (ZYNE), a publicly-traded company that is developing cannabinoid therapies for neuropsychiatric disorders, on behalf of investors in the company’s stock. The investigation regards possible violations of federal securities laws by Zynerba officers and directors.Silver Law Group is investigating Zynerba Pharmaceuticals (ZYNE), a publicly-traded company that is developing cannabinoid therapies for neuropsychiatric disorders, on behalf of investors in the company’s stock.

The investigation regards possible violations of federal securities laws by Zynerba officers and directors. Continue reading

Published on:

Curaleaf Holdings, Inc. (CURLF), a publicly-traded Massachusetts-based cannabis operator, is the subject of a class action lawsuit for alleged violations of federal securities laws.Curaleaf Holdings, Inc. (CURLF), a publicly-traded Massachusetts-based cannabis operator, is the subject of a class action lawsuit for alleged violations of federal securities laws.

Investors who purchased Curaleaf shares between November 21, 2018 and July 22, 2019 (the class period) are eligible to participate in the lawsuit. The deadline to apply to be lead plaintiff, or class representative, is October 4, 2019. Continue reading

Published on:

Silver Law Group is investigating Sonim Technologies, Inc. (SONM), a publicly-traded mobile phone company, for possible violations of federal securities laws. Sonim Technologies Issues Revised Financial Guidance On September 10, 2019, Sonim announced updated guidance for fiscal 2019 which stated that its net revenue would be lower than 2018 net revenues of $135.7 million. The company noted new product launch delays and software issues with the new products as reasons for the revised financial guidance. Sonim also announced that its CFO was leaving the company.Silver Law Group is investigating Sonim Technologies, Inc. (SONM), a publicly-traded mobile phone company, for possible violations of federal securities laws.

Sonim Technologies Issues Revised Financial Guidance

On September 10, 2019, Sonim announced updated guidance for fiscal 2019 which stated that its net revenue would be lower than 2018 net revenues of $135.7 million. The company noted new product launch delays and software issues with the new products as reasons for the revised financial guidance. Sonim also announced that its CFO was leaving the company. Continue reading

Published on:

Maxar Technologies Ltd (MAXR), a publicly-traded space technology company, is the subject of a class action lawsuit filed on behalf of investors who lost money investing in the company. If you lost money in Maxar Technologies or DigitalGlobal, we would like to talk to you. MDA DigitalGlobe Merger Maxar Technologies was created in October, 2017 with the merging of DigitalGlobe and MDA Holdings.Maxar Technologies Ltd (MAXR), a publicly-traded space technology company, is the subject of a class action lawsuit filed on behalf of investors who lost money investing in the company. If you lost money in Maxar Technologies or DigitalGlobe, we would like to talk to you.

MDA DigitalGlobe Merger

Maxar Technologies was created in October, 2017 with the merging of DigitalGlobe and MDA Holdings. Continue reading

Published on:

CannTrust (CTST), a publicly-traded producer of medical and recreational cannabis in Canada, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company. On July 8, 2019, news broke that CannTrust was growing cannabis in a greenhouse in Pelham, Ontario where regulatory approval was still pending. Holds were placed on the company’s inventory, and CannTrust says this will cause a product shortage. Analysts downgraded the stock.CannTrust (CTST), a publicly-traded producer of medical and recreational cannabis in Canada, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company.

On July 8, 2019, news broke that CannTrust was growing cannabis in a greenhouse in Pelham, Ontario where regulatory approval was still pending. Holds were placed on the company’s inventory, and CannTrust says this will cause a product shortage. Analysts downgraded the stock. Continue reading

Published on:

Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops, manufactures, and sells cancer-treating drugs, is being investigated for potential violations of federal securities laws. After market close on July 9, 2019, Oasmia announced that it had terminated its “engagement and cooperation” agreement with former executive chairman Julian Aleksov after a tax audit revealed missing money related to suspicious transactions between Oasmia and companies controlled by Aleksov and his former father-in-law.Oasmia Pharmaceutical AB (OASM), a publicly-traded company that develops, manufactures, and sells cancer-treating drugs, is being investigated for potential violations of federal securities laws.

Oasmia Terminates Relationship With Executive Chairman

After market close on July 9, 2019, Oasmia announced that it had terminated its “engagement and cooperation” agreement with former executive chairman Julian Aleksov after a tax audit revealed missing money related to suspicious transactions between Oasmia and companies controlled by Aleksov and his former father-in-law. Continue reading

Published on:

Owners of Conagra Brands stock (CAG) are suing the packaged foods giant, alleging they were tricked into approving their nearly $11 billion acquisition of Pinnacle Foods. Conagra, which is a component of the S&P 500, announced that it would acquire Pinnacle Foods in June, 2018. CEO Sean Connolly publicly assured investors that Conagra had done its due diligence into Pinnacle, which owns brands such as Birds Eye and Duncan Hines, and said that the two companies were a natural fit for each other.Owners of Conagra Brands stock (CAG) are suing the packaged foods giant, alleging they were tricked into approving their nearly $11 billion acquisition of Pinnacle Foods.

Conagra Justifies Acquisition Of Pinnacle Foods

Conagra, which is a component of the S&P 500, announced that it would acquire Pinnacle Foods in June, 2018. CEO Sean Connolly publicly assured investors that Conagra had done its due diligence into Pinnacle, which owns brands such as Birds Eye and Duncan Hines, and said that the two companies were a natural fit for each other. Continue reading

Published on:

Pyxus International, Inc. (PYX), a publicly-traded tobacco and vaporizer company, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company. Investors who purchased shares of Pyxus between June 7, 2018 and November 8, 2018 (the class period) may be eligible to participate in the lawsuit, which concerns violations of federal securities laws.Pyxus International, Inc. (PYX), a publicly-traded tobacco and vaporizer company, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company.

Pyxus Class Period And Lead Plaintiff Deadline

Investors who purchased shares of Pyxus between June 7, 2018 and November 8, 2018 (the class period) may be eligible to participate in the lawsuit, which concerns violations of federal securities laws. Continue reading

Contact Information